Your Results
Here are clinical trials that currently enrolling participants.
NATRON Clinical Study | Hypereosinophilic syndrome (HES)
The NATRON clinical study is researching an investigational drug for hypereosinophilic syndrome (HES) to determine if it helps to control HES when added to standard of care medications.
Visit Website
The SYMPHONY Study
The Symphony study is testing an oral investigational drug called BLU-945, alone and in combination with osimertinib, in adults with metastatic EGFR-mutated non-small cell lung cancer (NSCLC).
Visit Website
COVID-19 Clinical Trial Connect
Would you like to participate in a research study to help better understand or find a treatment or vaccine for COVID-19? There are numerous COVID-19 research studies being conducted through the United States to track people’s symptoms, learn more about our immune response to COVID-19 and investigate potential new treatments and vaccines. Whether you are healthy, have been exposed to COVID-19, are currently experiencing symptoms, have been diagnosed or have recovered, you may be eligible to take part in a local COVID-19 research study.
Visit Website
The CardinalHF Study
The CARDINAL-HF study is testing an experimental drug called CRD-740. We want to find out if CRD-740 is safe and effective for the treatment of heart failure. If you have been diagnosed with chronic heart failure for at least 6 months, you may be able to join this study.
Visit Website
COPD Studies
If you have had a COPD exacerbation in the last 12 months that required medical attention, you may qualify to participate in a clinical research study. We are testing new investigational therapies to find out if they can reduce airway inflammation and improve COPD symptoms. This website can help you and your doctor decide if one of the current COPD research studies could be an option for you.
Visit Website
GENESIS LGMD Studies
The mission to find new treatments for limb-girdle muscular dystrophy (LGMD) is underway. If you are living with LGMD, you may be able to join a clinical study. With the help of people like you, we can find a way forward. Thank you for considering participation in a study.
Visit Website
Takeda MSA Clinical Study
If you have (or a loved one has) symptoms that your doctor believes may be signs of multiple system atrophy (MSA), you might be unsure of where to turn. The journey from first symptoms to a diagnosis of possible or probable MSA and beyond can be confusing and frustrating. You are not alone. Joining a clinical study may be one option for you to think about.
Visit Website
PACIFIC Itch Study | Intense. Unrelenting. Distressing. Itching.
If you have itch due to liver disease, consider participating in pruritus research. The PACIFIC study is testing an investigational drug (EP547) to see if it can help reduce itch (pruritus) in adults with Primary Biliary Cholangitis (PBC) or Primary Sclerosing Cholangitis (PSC). By participating in this study, you may be helping to advance development of a potential new treatment.
Visit Website
The CONFIDENCE Trial | Do you have chronic kidney disease and type 2 diabetes?
You are not alone. You may be able to join others like yourself by taking part in a research study. The CONFIDENCE Study is evaluating the effects that two study drugs have when they are given together compared to when they are given alone.
Visit Website
IgA Nephropathy Clinical Research Study
The ALIGN Study is testing atrasentan, an investigational medication, that has the potential to reduce protein in the urine and preserve kidney function in patients with immunoglobulin A nephropathy (IgAN).
Visit Website